News
03-30-2010, 04:52 AM
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
More... (http://www.news-medical.net/news/20100330/Court-rules-certain-claims-covering-isolated-DNA-sequences-in-patents-covering-BRACAnalysis-as-invalid.aspx)
More... (http://www.news-medical.net/news/20100330/Court-rules-certain-claims-covering-isolated-DNA-sequences-in-patents-covering-BRACAnalysis-as-invalid.aspx)